AI-Powered PK Reporting: From Days to Minutes
CertaraDecember 4, 2025
From Insight to Impact: Certainty EMEA 2025
See how GenAI, unified digital trials, and a Totality of Evidence approach transform regulatory docs,…
CertaraNovember 17, 2025
ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™
At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…
CertaraNovember 13, 2025
Certara Reports Third Quarter 2025 Financial Results
RADNOR, PA— November 6, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…
CertaraNovember 6, 2025
Certara Expands Biosimulation Market with AI-Driven QSP Platform
Discover how Certara IQ accelerates drug development through scalable, QSP Modeling with AI-Powered Biosimulation.
CertaraOctober 30, 2025
At Certara, we’re proud to support WBUR, Boston’s NPR.
Certara supports public radio because NPR is aligned with our values and helps us spread…
CertaraOctober 29, 2025
Best Practices for AI Prompt Engineering in Life Sciences in 2025
AI prompt engineering is an essential skill for using LLMs. Read our blog for best…
CertaraOctober 23, 2025
Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results
Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…
CertaraOctober 15, 2025
